ImmunityBio (IBRX) Climbs 7.76% on Europe Expansion
In a statement, ImmunityBio Inc.
Immunitybio Inc. (IBRX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Woodline Partners Michael Rockefeller And Karl Kroeker | 5,297,725 | $13,032,404 | +54% | 0.06% |
| 2. | Tang Capital Management Kevin C. Tang | 2,333,333 | $5,739,999 | 0.22% | |
| 3. | Citadel Investment Group Ken Griffin | 1,130,748 | $2,781,641 | +44% | 0% |
| 4. | Renaissance Technologies Jim Simons | 1,016,199 | $2,499,850 | 0% | |
| 5. | Squarepoint Ops LLC Maxime Fortin (Cio) | 1,013,291 | $2,492,696 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.75 | 485 | $1,333.75 | 71,915 | 2023-06-05 | Filing | |
| $2.77 | 48,000 | $132,960.00 | 71,430 | 2023-06-05 | Filing | |
| $2.72 | 23,430 | $63,729.60 | 23,430 | 2023-06-05 | Filing | |
| $2.90 | 10,000 | $29,000.00 | 25,000 | 2023-06-02 | Filing | |
| $2.80 | 10,000 | $28,000.00 | 15,000 | 2023-06-02 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $10.12 | 14,801 | $149,795.00 | 200,617 | 2021-08-23 | Filing | |
| $10.00 | 9,976 | $99,807.88 | 215,418 | 2021-08-20 | Filing | |
| $10.03 | 2,133 | $21,389.08 | 225,394 | 2021-08-18 | Filing | |
| $10.12 | 43,398 | $439,361.35 | 227,527 | 2021-08-17 | Filing | |
| $16.18 | 88,787 | $1,436,822.26 | 3,102,507 | 2021-05-25 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 27,655,205 | $68,031,804 | 0% | |
| 2. | 19,810,963 | $48,734,970 | 0% | |
| 3. | 12,835,579 | $31,575,524 | 0% | |
| 4. | 11,315,813 | $27,836,900 | 0% | |
| 5. | 6,890,065 | $16,952,381 | 0% |
News See All
ImmunityBio, Inc. (IBRX): A Bull Case Theory
We came across a bullish thesis on ImmunityBio, Inc. on Investment Ideas by Antonio’s Substack by Antonio Linares. In this article, we will summarize the bulls’ thesis on IBRX.
ImmunityBio (IBRX) Slashes 9% on Lack of Leads
ImmunityBio dropped for a second day on Tuesday, shedding 9.13 percent to close at $2.09 apiece as investors repositioned portfolios while waiting for fresh catalysts from the ongoing Piper Sandler 37th...
ImmunityBio (IBRX) Soars 10.8% Ahead of Health Conferences
ImmunityBio rallied for a second day on Friday, soaring 10.80 percent to end at $2.36 apiece, mimicking optimism of the broader market and loading positions ahead of expected updates from its participation...
Is ImmunityBio Inc. (IBRX) The Best US Stock To Buy Under $20?
ImmunityBio Inc. (NASDAQ:IBRX) is among the best US stocks to buy under $20. As of November 26, ImmunityBio Inc.
10 Best US Stocks to Buy Under $20
Every investor is looking to invest in the ‘best’ stock, but that word means something different to each of us. The real differentiation comes when that stock also trades at a low price.
H.C. Wainwright Asserts Buy Rating on Immunitybio Inc. (IBRX) as Net Loss Narrows on Robust Product Revenue
Immunitybio Inc. (NASDAQ:IBRX) is one of the fastest-growing penny stocks to buy now.
10 Fastest Growing Penny Stocks to Buy Now
Have the markets peaked? That’s the big question following a blockbuster year in which equity markets raced to record highs.
12 Healthcare Stocks with Insider Buying in 2025
In 2025, there will be a complicated combination of opportunities and difficulties in the healthcare innovation landscape, with divergent trends in technology adoption, investment, and fundraising.
Hedge Fund Resource Center Billionaire Hedge Funds
